MyFinsight
Home
Blog
About
Contact
Download
Download image
Sale of common stock
under at-the- market...
$3,882K
Sale of common stock
and warrants
$818K
Business acquisition,
net of cash acquired
-$366K
Net cash provided by
financing activities
$4,700K
Net cash provided by
investing activity
$366K
Effect of exchange rate
changes on cash and cash...
$5K
Net increase in cash
and cash...
$2,678K
Canceled cashflow
$2,393K
Stock based
compensation
$7,444K
Common stock issued for
services rendered
-$7,244K
Accounts payable and
accrued expenses
$5,638K
Depreciation and
amortization
$577K
Allowance for credit
losses on accounts...
-$109K
Non-cash lease expense
$82K
Unbilled revenue
$13K
Net cash used in
operating activities
-$2,393K
Canceled cashflow
$21,107K
Net loss
-$23,169K
Gain on settlement of
debt
$196K
Operating lease
liabilities
-$87K
Prepaid expenses
$45K
Sales tax receivable
-$3K
Back
Back
Cash Flow
source: myfinsight.com
BioSig Technologies, Inc. (BSGM)
BioSig Technologies, Inc. (BSGM)